BLFS
Price
$24.11
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
118 days until earnings call
GKOS
Price
$143.25
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
96 days until earnings call
Ad is loading...

BLFS vs GKOS

Header iconBLFS vs GKOS Comparison
Open Charts BLFS vs GKOSBanner chart's image
BioLife Solutions
Price$24.11
Change-$0.00 (-0.00%)
Volume$984.7K
CapitalizationN/A
Glaukos
Price$143.25
Change-$0.00 (-0.00%)
Volume$341.16K
CapitalizationN/A
BLFS vs GKOS Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BLFS vs. GKOS commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and GKOS is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BLFS: $24.11 vs. GKOS: $143.25)
Brand notoriety: BLFS and GKOS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 293% vs. GKOS: 62%
Market capitalization -- BLFS: $810.87M vs. GKOS: $4.61B
BLFS [@Medical Specialties] is valued at $810.87M. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileGKOS’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • GKOS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and GKOS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while GKOS’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 6 bearish.
  • GKOS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -9.36% price change this week, while GKOS (@Medical Specialties) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.22%. For the same industry, the average monthly price growth was +0.64%, and the average quarterly price growth was +2.87%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

GKOS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-2.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than BLFS($811M). GKOS YTD gains are higher at: 80.211 vs. BLFS (48.369). BLFS has higher annual earnings (EBITDA): -45.24M vs. GKOS (-82.12M). GKOS has more cash in the bank: 295M vs. BLFS (51.7M). BLFS has less debt than GKOS: BLFS (42.7M) vs GKOS (384M). GKOS has higher revenues than BLFS: GKOS (315M) vs BLFS (143M).
BLFSGKOSBLFS / GKOS
Capitalization811M4.61B18%
EBITDA-45.24M-82.12M55%
Gain YTD48.36980.21160%
P/E Ratio238.10N/A-
Revenue143M315M45%
Total Cash51.7M295M18%
Total Debt42.7M384M11%
FUNDAMENTALS RATINGS
BLFS vs GKOS: Fundamental Ratings
BLFS
GKOS
OUTLOOK RATING
1..100
573
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
8226
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
3838
P/E GROWTH RATING
1..100
2074
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GKOS's Valuation (93) in the Medical Specialties industry is in the same range as BLFS (95). This means that GKOS’s stock grew similarly to BLFS’s over the last 12 months.

GKOS's Profit vs Risk Rating (26) in the Medical Specialties industry is somewhat better than the same rating for BLFS (82). This means that GKOS’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's SMR Rating (94) in the Medical Specialties industry is in the same range as GKOS (95). This means that BLFS’s stock grew similarly to GKOS’s over the last 12 months.

BLFS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as GKOS (38). This means that BLFS’s stock grew similarly to GKOS’s over the last 12 months.

BLFS's P/E Growth Rating (20) in the Medical Specialties industry is somewhat better than the same rating for GKOS (74). This means that BLFS’s stock grew somewhat faster than GKOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSGKOS
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
0%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X90584.1640002628.351600
+2.99%
Bitcoin cryptocurrency
TSLA330.241.75
+0.53%
Tesla
AAPL225.120.89
+0.40%
Apple
SPY597.190.29
+0.05%
SPDR® S&P 500® ETF Trust
GME26.46-0.38
-1.42%
GameStop Corp

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-9.02%
AZTA - BLFS
52%
Loosely correlated
-3.22%
VCYT - BLFS
49%
Loosely correlated
+3.37%
MASS - BLFS
47%
Loosely correlated
-19.86%
RGEN - BLFS
45%
Loosely correlated
+1.27%
ALGN - BLFS
45%
Loosely correlated
-1.85%
More

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ALGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-0.26%
ALGN - GKOS
45%
Loosely correlated
-1.85%
ICUI - GKOS
42%
Loosely correlated
-1.80%
PRCT - GKOS
40%
Loosely correlated
-3.45%
BLFS - GKOS
36%
Loosely correlated
-9.02%
CTKB - GKOS
35%
Loosely correlated
-3.69%
More